HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 1, 2006, Pages 68-77

  Willam, Carsten ^a   Maxwell, Patrick H ^a   Nichols, Lynn ^a   Lygate, Craig ^a   Tian, Ya Min ^a   Bernhardt, Wanja ^b   Wiesener, Michael ^b   Ratcliffe, Peter J ^a   Eckardt, Kai Uwe ^b   Pugh, Christopher W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Histo(path)ology; Hypoxia; Hypoxia inducible factor; Infarction; Ischemia; Prolyl hydroxylase

Indexed keywords

HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE 1; HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE 2; HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE 3; ISOENZYME; MESSENGER RNA; OXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GENE EXPRESSION; GENE INDUCTION; HEART; HEART MUSCLE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN SENSING; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; RIBONUCLEASE PROTECTION ASSAY; TESTIS; TISSUE DISTRIBUTION;

ANIMALS; ANOXIA; CORONARY VESSELS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEODOMAIN PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1; IMMEDIATE-EARLY PROTEINS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; RATS, WISTAR; REFERENCE VALUES; RNA, MESSENGER;

ANIMALIA;

EID: 33745665335     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.04.009     Document Type: Article

References (32)

1. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
2. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
3. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
4. Masson N., Willam C., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 20 (2001) 5197-5206
5. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
6. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
7. Kotch L.E., Iyer N.V., Laughner E., and Semenza G.L. Defective vascularization of HIF-1a-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209 (1999) 254-267
8. Ryan H.E., Lo J., and Johnson R.S. HIF-1a is required for solid tumor formation and embryonic vascularization. EMBO J 17 (1998) 3005-3015
9. Hu C.-J., Wang L.-Y., Chodosh L.A., Keith B., and Simon M.C. Differential roles of hypoxia-inducible factor 1a (HIF-1a) and HIF-2a in hypoxic gene regulation. Mol Cell Biol 23 (2003) 9361-9374
10. Clifford S.C., Cockman M.E., Smallwood A.C., Mole D.R., Woodward E.R., Maxwell P.H., et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 10 (2001) 1029-1038
11. Ang S.O., Chen H., Hirota K., Gordeuk V.R., Jelinek J., Guan Y., et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32 4 (2002) 614-621
12. Percy M.J., Zhao Q., Flores A., Harrison C., Lappin T.R., Maxwell P.H., et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A 10 (2006) 654-659
13. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., and Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 22 (2003) 4082-4090
14. Appelhoff R.J., Tian Y.M., Raval R.R., Turley H., Harris A.L., Pugh C.W., et al. Differential function of the prolyl hydroxylases, PHD1, 2 and 3 in the regulation of Hypoxia inducible factor (HIF). J Biol Chem 279 37 (2004) 38458-38465
15. Giaccia A., Siim B.G., and Johnson R.S. HIF-1 as a target for drug development. Nat Rev, Drug Discov 2 (2003) 803-811
16. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8 (2002) S62-S67
17. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9 (2003) 677-684
18. Wax S.D., Rosenfield C.L., and Taubman M.B. Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J Biol Chem 269 (1994) 13041-13047
19. Wykoff C.C., Beasley N.J., Watson P.H., Turner K.J., Pastorek J., Sibtain A., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 (2000) 7075-7083
20. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 94 (1997) 8104-8109
21. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92 (1998) 2260-2268
22. Metzen E., Berchner-Pfannschmidt U., Stengel P., Marxsen J.H., Stolze I., Klinger M., et al. Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci 116 (2003) 1319-1326
23. Lieb M.E., Menzies K., Moschella M.C., Ni R., and Taubman M.B. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 80 (2002) 421-426
24. Oehme F., Ellinghaus P., Kolkhof P., Smith T.J., Ramakrishnan S., Hutter J., et al. Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem Biophys Res Commun 296 (2002) 343-349
25. Willam C., Nicholls L.G., Ratcliffe P.J., Pugh C.W., and Maxwell P.H. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor. Adv Enzyme Regul 44 (2004) 75-92
26. Marti H.H., Katschinski D.M., Wagner K.F., Schaffer L., Stier B., and Wenger R.H. Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Mol Endocrinol 16 (2002) 234-243
27. Wax S.D., Tsao L., Lieb M.E., Fallon J.T., and Taubman M.B. SM-20 is a novel 40-kd protein whose expression in the arterial wall is restricted to smooth muscle. Lab Invest 74 (1996) 797-808
28. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A 99 (2002) 13459-13464
29. Warnecke C., Griethe W., Weidemann A., Jurgensen J.S., Willam C., Bachmann S., et al. Activation of the hypoxia-inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J 17 9 (2003) 1186-1188
30. Mole D.R., Schlemminger I., McNeill L.A., Hewitson K.S., Pugh C.W., Ratcliffe P.J., et al. 2-oxoglutarate analogue inhibitors of hif prolyl hydroxylase. Bioorg Med Chem Lett 13 (2003) 2677-2680
31. Ockaili R., Natarajan R., Salloum F., Fisher B.J., Jones D., Fowler A.A., et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol, Heart Circ Physiol 289 2 (2005) H542-H548
32. Nwogu J.I., Geenen D., Bean M., Brenner M.C., Huang X., and Buttrick P.M. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation 104 (2001) 2216-2221